Jim Simons Ligand Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,000 shares of LGND stock, worth $321,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,000

Previous 18,200 83.52%

Holding current value

$321,450

Previous $1.53 Million 80.43%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$82.7 - $110.11 $1.26 Million - $1.67 Million	-15,200 Reduced 83.52%	3,000 $300,000
Q2 2024 Aug 09, 2024	SELL	$68.53 - $87.91 $1.98 Million - $2.54 Million	-28,900 Reduced 61.36%	18,200 $1.53 Million
Q1 2024 May 13, 2024	SELL	$68.64 - $89.2 $1.32 Million - $1.71 Million	-19,200 Reduced 28.96%	47,100 $3.44 Million
Q4 2023 Feb 13, 2024	BUY	$49.57 - $72.63 $525,442 - $769,878	10,600 Added 19.03%	66,300 $4.74 Million
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $782,838 - $966,511	13,300 Added 31.37%	55,700 $3.34 Million
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $876,078 - $999,558	12,600 Added 42.28%	42,400 $3.06 Million
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $348,051 - $408,524	5,300 Added 21.63%	29,800 $2.19 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $481,416 - $754,572	7,800 Added 46.71%	24,500 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $12 - $139,182	-1,294 Reduced 7.19%	16,700 $1.44 Million
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $1.34 Million - $2.11 Million	17,994 New	17,994 $1.61 Million
Q3 2020 Nov 13, 2020	SELL	$89.56 - $126.72 $12.1 Million - $17.2 Million	-135,544 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $31.7 Million - $57.4 Million	-464,400 Reduced 77.41%	135,544 $15.2 Million
Q1 2020 May 14, 2020	SELL	$63.37 - $107.88 $26.7 Million - $45.4 Million	-421,245 Reduced 41.25%	599,944 $43.6 Million
Q4 2019 Feb 13, 2020	SELL	$96.94 - $113.59 $19.2 Million - $22.5 Million	-198,225 Reduced 16.26%	1,021,189 $107 Million
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $5.3 Million - $7.38 Million	-61,394 Reduced 4.79%	1,219,414 $121 Million
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $14.5 Million - $17.4 Million	-134,900 Reduced 9.53%	1,280,808 $146 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $6.9 Million - $9.28 Million	-65,111 Reduced 4.4%	1,415,708 $178 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $190 Million - $403 Million	1,480,819 New	1,480,819 $201 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.81B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account